Vesa Jouni, Chin Mark H, Oelgeschläger Kathrin, Isosomppi Juha, DellAngelica Esteban C, Jalanko Anu, Peltonen Leena
Department of Human Genetics, University of California at Los Angeles School of Medicine, Gonda Neuroscience and Genetics Research Center, Los Angeles, California 90095-7088, USA.
Mol Biol Cell. 2002 Jul;13(7):2410-20. doi: 10.1091/mbc.e02-01-0031.
Neuronal ceroid lipofuscinoses (NCLs) are neurodegenerative storage diseases characterized by mental retardation, visual failure, and brain atrophy as well as accumulation of storage material in multiple cell types. The diseases are caused by mutations in the ubiquitously expressed genes, of which six are known. Herein, we report that three NCL disease forms with similar tissue pathology are connected at the molecular level: CLN5 polypeptides directly interact with the CLN2 and CLN3 proteins based on coimmunoprecipitation and in vitro binding assays. Furthermore, disease mutations in CLN5 abolished interaction with CLN2, while not affecting association with CLN3. The molecular characterization of CLN5 revealed that it was synthesized as four precursor forms, due to usage of alternative initiator methionines in translation. All forms were targeted to lysosomes and the longest form, translated from the first potential methionine, was associated with membranes. Interactions between CLN polypeptides were shown to occur with this longest, membrane-bound form of CLN5. Both intracellular targeting and posttranslational glycosylation of the polypeptides carrying human disease mutations were similar to wild-type CLN5.
神经元蜡样脂褐质沉积症(NCLs)是一类神经退行性贮积病,其特征为智力发育迟缓、视力衰退、脑萎缩以及多种细胞类型中出现贮积物质的积累。这些疾病由普遍表达的基因突变引起,其中已知的有六种。在此,我们报告三种具有相似组织病理学特征的NCL疾病形式在分子水平上存在关联:基于免疫共沉淀和体外结合试验,CLN5多肽与CLN2和CLN3蛋白直接相互作用。此外,CLN5中的疾病突变消除了与CLN2的相互作用,而不影响与CLN3的结合。CLN5的分子特征表明,由于翻译过程中使用了不同的起始甲硫氨酸,它以四种前体形式合成。所有形式都靶向溶酶体,从第一个潜在甲硫氨酸翻译而来的最长形式与膜相关。CLN多肽之间的相互作用显示发生在这种最长的、与膜结合的CLN5形式上。携带人类疾病突变的多肽的细胞内靶向和翻译后糖基化与野生型CLN5相似。